www.fdanews.com/articles/101517-isis-excaliard-collaborate-to-develop-antisense-drugs-for-fibrotic-diseases

Isis, Excaliard Collaborate to Develop Antisense Drugs for Fibrotic Diseases

November 27, 2007

Isis Pharmaceuticals, Inc. and Excaliard Pharmaceuticals, Inc. announced a new collaboration to discover and develop antisense drugs for the local treatment of fibrotic diseases, including scarring.
FreshNews.com